IDEAS home Printed from https://ideas.repec.org/p/ohe/briefg/002165.html
   My bibliography  Save this paper

Indication-Based Pricing (IBP) Discussion Paper: Should drug prices differ by indication?

Author

Listed:
  • Amanda Cole;Adrian Towse;Bernarda Zamora

Abstract

Increasingly, scientific advances are delivering new medicines that deliver improved survival and quality of life across multiple treatment indications. Indication-Based Pricing (IBP) has been proposed as a way to better link price with value. In this short Discussion Paper, we outline the major issues including the potential benefits of IBP, potential draw-backs, and considerations for implementation. We then ask for your views. To submit your thoughts, please access the survey which accompanies the Discussion Paper or use the following link: https://www.surveymonkey.co.uk/r/IBP_Consultation Consultation closing date: Monday, 30 September 2019. Increasingly, scientific advances are providing new medicines that provide improved survival and quality of life across multiple treatment indications. Indication-Based Pricing (IBP) has been proposed as a better value for money. In this short Discussion Paper, we outline the major issues including the potential benefits of IBP, potential draw-backs, and considerations for implementation. We then ask for your views. The survey that accompanied this report is now closed. Results will be published shortly. .................................................. .................................................. ............................Fixation du prix selon l’indication thérapeutique (FPIT). Le prix des médicaments devrait-il différer selon l’indication thérapeutique? De plus en plus, la science à l’origine du développement des médicaments permettra améliorer la survie et qualité de vie dans plusieurs indications thérapeutiques. Aussi, il convient de rechercher de nouveaux mécanismes de rémunération répondant à cette situation. Un mécanisme permet au système de santé de fixer, pour un médicament, différents prix pour différentes indications thérapeutiques : c’est la fixation du prix selon l’indication thérapeutique (FPIT) qui permet lier le prix avec la valeur d’un médicament selon les différentes indications. Nous souhaiterions échanger et recueillir différents points de vue sur les avantages et inconvénients potentiels pour réfléchir sur la mise en œuvre du FPIT. Nous souhaiterions connaître votre propre point de vue. L’ enquête est fermée. Les résultats seront bientôt publiés.

Suggested Citation

  • Amanda Cole;Adrian Towse;Bernarda Zamora, 2019. "Indication-Based Pricing (IBP) Discussion Paper: Should drug prices differ by indication?," Briefing 002165, Office of Health Economics.
    • Handle: RePEc:ohe:briefg:002165
    as

    Download full text from publisher

    File URL: https://www.ohe.org/publications/indication-based-pricing-ibp-discussion-paper-should-drug-prices-differ-indication/attachment-rebrand-ibp-discussion-paper_final-30-september-2019/
    Download Restriction: no
    ---><---

    More about this item

    Keywords

    Indication-Based Pricing (IBP) Discussion Paper: Should drug prices differ by indication?;

    JEL classification:

    • I1 - Health, Education, and Welfare - - Health

    NEP fields

    This paper has been announced in the following NEP Reports:

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:ohe:briefg:002165. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Publications Manager (email available below). General contact details of provider: https://edirc.repec.org/data/ohecouk.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.